Results 151 to 160 of about 5,784 (166)

Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial

European Journal of Cancer, 2017
Axel Hauschild, Kate Fife, Reinhard Dummer   +2 more
exaly  

Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjects

British Journal of Clinical Pharmacology, 2012
Young G Shin, Cornelis E C A Hop, Richard A Graham   +2 more
exaly  

Vismodegib, an antagonist of hedgehog signaling, directly alters taste molecular signaling in taste buds

Cancer Medicine, 2015
Josephine Egan, Jeong Seon Yoon, Wei-Na Cong   +2 more
exaly  

Enhanced skin delivery of vismodegib by microneedle treatment

Drug Delivery and Translational Research, 2015
Hiep X Nguyen, Ajay K Banga
exaly  

Nanoformulation for potential topical delivery of Vismodegib in skin cancer treatment

International Journal of Pharmaceutics, 2019
Badhin Gómez, Christian Zevallos-Delgado, Massimo Fresta   +2 more
exaly  

A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma

Journal of the American Academy of Dermatology, 2015
Howard Sofen, Tiffani K Hamilton, Leonard H Goldberg   +2 more
exaly  

Vismodegib: An Inhibitor of the Hedgehog Signaling Pathway in the Treatment of Basal Cell Carcinoma

Annals of Pharmacotherapy, 2014
Cindy L O’Bryant
exaly  

Discovery and preclinical development of vismodegib

Expert Opinion on Drug Discovery, 2014
Robert L Yauch, Stephen E. Gould, Frederic J de Sauvage   +2 more
exaly  

Polymeric micelle nanocarriers for targeted epidermal delivery of the hedgehog pathway inhibitor vismodegib: formulation development and cutaneous biodistribution in human skin

Expert Opinion on Drug Delivery, 2019
Mayank Singhal, Yogeshvar N. Kalia
exaly  

Pilomatricomas secondary to treatment with vismodegib

JAAD Case Reports, 2019
José-María Ortiz-Salvador, José Luis Sánchez-Carazo, Blanca Ferrer-Guillén   +2 more
exaly